Page 5 - Bluejay Diagnostics News Today

Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totalling 30,300 shares, a decline of 46.7% from the March 15th total of 56,800 shares. Approximately 0.3% of the company’s stock are sold short. Based on an average […]

Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) shares were down 2.7% during mid-day trading on Tuesday . The stock traded as low as $0.40 and last traded at $0.40. Approximately 21,952 shares traded hands during trading, a decline of 80% from the average daily volume of 110,213 shares. The stock had previously closed at $0.41. […]

Shares of Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) traded down 2.7% on Tuesday . The stock traded as low as $0.40 and last traded at $0.40. 21,952 shares were traded during trading, a decline of 80% from the average session volume of 110,213 shares. The stock had previously closed at $0.41. Bluejay Diagnostics Stock […]

20.03.2023 - ACTON, Mass., March 20, 2023 (GLOBE NEWSWIRE) - Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid tests using whole blood on its Symphony platform to improve patient outcomes in ...

Webinar to be held Thursday, August 25th @ 11:00am EDT...

Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) is one of 216 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its rivals? We will compare Bluejay Diagnostics to similar businesses based on the strength of its analyst recommendations, earnings, valuation, dividends, profitability, institutional ownership and risk. Analyst Ratings This is […]

ACTON, Mass., July 26, 2022 -- Bluejay Diagnostics, Inc. , a medical diagnostics company focused on developing cost-effective, rapid, near-patient tests for triage and monitoring of disease...

Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) saw a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 117,400 shares, a drop of 40.4% from the May 15th total of 197,100 shares. Approximately 1.2% of the shares of the company are sold short. Based on […]

Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) and Beyond Air (NASDAQ:XAIR – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings. Institutional and Insider Ownership 45.4% of Bluejay Diagnostics shares […]

Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) and INVO Bioscience (NASDAQ:INVO – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, profitability and institutional ownership. Profitability This table compares Bluejay Diagnostics and INVO Bioscience’s […]